Persistent URL of this record https://hdl.handle.net/1887/3765914
Documents
-
- Full Text
- under embargo until 2025-06-25
-
- Download
- Title Pages_Contents
- open access
-
- Chapter 2
- under embargo until 2025-06-25
- Full text at publishers site
-
- Download
- Chapter 3
- open access
- Full text at publishers site
-
- Download
- Chapter 4
- open access
- Full text at publishers site
-
- Download
- Chapter 5
- open access
- Full text at publishers site
-
- Download
- Chapter 6
- open access
- Full text at publishers site
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
Nanoparticle-based combination drug delivery systems for effective cancer treatment
Our findings show that the developed nanoparticles can improve drug delivery to tumors while reducing side effects to the rest of the body. Moreover, we have shown that lipids can be used to reprogramme immune cells in the tumor environment, causing them to exhibit anti-tumor activity. In addition, the nanoparticles show excellent delivery capabilities in 3D models of skin cancer, allowing them to kill skin tumor cells more effectively. The societal relevance of our research lies in improving cancer treatment options, particularly by reducing side effects and increasing the...Show moreOur research focuses on developing advanced nanoparticles for cancer treatment, with a focus on reducing side effects and improving efficacy. We have developed nanoparticles that can not only target cancer cells but also serve as imaging agents to monitor treatment. In addition, we have investigated how lipids and immune cells in the tumor environment can be manipulated to improve cancer therapy.
Our findings show that the developed nanoparticles can improve drug delivery to tumors while reducing side effects to the rest of the body. Moreover, we have shown that lipids can be used to reprogramme immune cells in the tumor environment, causing them to exhibit anti-tumor activity. In addition, the nanoparticles show excellent delivery capabilities in 3D models of skin cancer, allowing them to kill skin tumor cells more effectively. The societal relevance of our research lies in improving cancer treatment options, particularly by reducing side effects and increasing the effectiveness of therapies. These findings provide new insights and approaches for the development of cancer therapies, which can contribute to a better quality of life for patients.
We have achieved these results through a multidisciplinary approach using nanotechnology, chemotherapeutic drugs and knowledge of the tumor environment. Our findings are special because they offer promising new strategies for cancer treatment using cutting-edge technologies and insights into tumor biology.Show less
- All authors
- He, Y.
- Supervisor
- Buchem, M.A. van
- Co-supervisor
- Eich, C.
- Committee
- Dijke, P. ten; Neefjes, J.J.C.; Gelder, T. van; Ghalbzouri, A. el; Djanashvili, K.
- Qualification
- Doctor (dr.)
- Awarding Institution
- Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University
- Date
- 2024-06-25
- ISBN (print)
- 9789465061078
Funding
- Sponsorship
- H2020-MSCA-RISE grant number 777682-CANCER and 872860-PRISAR2